Indication

Complicated skin and skin structure Streptococcus dysgalactiae infection

Complicated skin and skin structure Streptococcus dysgalactiae infection is a severe, deep-seated bacterial infection of the integumentary system involving the dermis, subcutaneous tissue, fascial planes, or underlying muscle. Read more about Complicated skin and skin structure Streptococcus dysgalactiae infection

43 drugs 38 manufacturers

Advertisement

Drugs that treat it

Common Complicated skin and skin structure Streptococcus dysgalactiae infection therapies.

Showing 37–43 of 43 drugs

DALBAVANCIN HCL

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS·COMPLICATED SKIN AND SKIN STRUCTURE STAPHYLOCOCCUS AUREUS INFECTION·+6
TEVA PHARM

DALBAVANCIN HCL

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS·COMPLICATED SKIN AND SKIN STRUCTURE STAPHYLOCOCCUS AUREUS INFECTION·+6
FRESENIUS KABI

DALBAVANCIN HCL

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS·COMPLICATED SKIN AND SKIN STRUCTURE STAPHYLOCOCCUS AUREUS INFECTION·+6
MEITHEAL PHARMA

DAPTOMYCIN

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS·STAPHYLOCOCCUS AUREUS SEPTICEMIA·+6
Endo USA

DALBAVANCIN HCL

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS·COMPLICATED SKIN AND SKIN STRUCTURE STAPHYLOCOCCUS AUREUS INFECTION·+6
LONG GROVE PHAR

DALBAVANCIN HCL

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS·COMPLICATED SKIN AND SKIN STRUCTURE STAPHYLOCOCCUS AUREUS INFECTION·+6
Pfizer Laboratories

DALBAVANCIN HCL

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS·COMPLICATED SKIN AND SKIN STRUCTURE STAPHYLOCOCCUS AUREUS INFECTION·+6
BE PHARMACEUTIC
Filter & compare in the drug finder →Opens the drug finder with Complicated skin and skin structure Streptococcus dysgalactiae infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Complicated skin and skin structure Streptococcus dysgalactiae infection.

Complicated skin and skin structure Streptococcus dysgalactiae infection is a severe, deep-seated bacterial infection of the integumentary system involving the dermis, subcutaneous tissue, fascial planes, or underlying muscle.

Primarily caused by the beta-hemolytic Lancefield group C or G pathogen Streptococcus dysgalactiae (predominantly subspecies equisimilis), these infections frequently arise in patients with underlying systemic comorbidities, cutaneous breaches, or impaired lymphatic drainage.

Pathophysiologically, the bacterium invades deep tissue spaces via extracellular virulence factors and toxins, triggering intense localized inflammation, tissue necrosis, or abscess formation, often presenting as extensive cellulitis, surgical wound infections, or necrotizing fasciitis accompanied by systemic signs of toxicity.

Personalize your experience

Follow Complicated skin and skin structure Streptococcus dysgalactiae infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it